January 6, 2025—The FDA announced it has issued draft guidance for recommendations to support development and marketing of safe and effective artificial intelligence (AI)–enabled devices throughout the device’s Total Product Life Cycle. The FDA will hold a webinar on February 18, 2025, to discuss the draft guidance.